- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02216604
Exercise in Pediatric Cancer Patient Undergoing Anti-Cancer Treatment (ONKOKIDS-HD)
March 11, 2019 updated by: German Cancer Research Center
Physical Activity Intervention Program for Childhood Cancer Patients Under Chemo- and/or Radiation Therapy
Today about 80% childhood cancer patients become long-time survivors.
In spite of the high cure rates the diagnosis cancer is associated with a variety of disease and treatment-related psychological and physical impairments mostly present into adulthood.
So the attention has to focus on the improvement of these problems such as motor limitation, dysfunction of the cardiovascular system, reduced muscle strength, overweight, osteoporosis and diminished quality of life (Qol).
Although exercisel intervention studies in this field are generally scarce, the results of these studies are promising.
Up to now studies during the acute phase of treatment are missing almost completely.
The aim of this feasibility study is to evaluate the potential benefits of a modular exercise intervention program for childhood cancer patients startunf in parallel with treatment and longlasting for one year.
Across two years cancer patients of the Children's Hospital of the University Clinic of Heidelberg aged 5-21 years, free of any contraindications for physical activity will be recruited.
All participants are asked to complete a physical assessment battery (strength, endurance and balance capacity, posture control, functional mobility, range of motion) and additionally two questionnaires concerning Qol and motivation, at baseline and every three months following one year
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Heidelberg, Germany, 69120
- Children's Hospital of the University Hospital of Heidelberg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 21 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- pediatric cancer diagnosis (primary leukemia, brain tumors and bone tumors
- date of diagnosis not longer than 8 weeks ago
Exclusion Criteria:
- severe cardiac impairment
- bone metastasis inducing skeletal fragility
- other orthopedic diseases or any other circumstance that would impede ability to give informed consent or adherence to study requirements.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
Multimodal Exercise intervention (console-based training, age-specific resistance training and body awareness)
|
During their inpatient hospitalization the participants perform 3-5x weekly guided training sessions about 15-30min.
The intervention includes: game console-based training using Nintendo Wii® (endurance, strength endurance and balance), age-specific resistance training and sessions of body awareness.
During the outpatient phases the participants perform a home-based exercise training 3-5x weekly using a training manual.
In addition, the patients obtain a movement diary and a pedometer for documenting their activity level.
|
|
No Intervention: Control
age, disease and gender matched
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility after 6 month
Time Frame: after primary treatment (6 month)
|
Will be measured as the proportion of patients following the exercise prescription.
|
after primary treatment (6 month)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical performance
Time Frame: after primary treatment (6 month) and after one year
|
Strength (handheld dynamometer), endurance and balance capacity (TUDS, one leg stand), postural control functional mobility (posturomed & force plate), range of motion (goniometer)
|
after primary treatment (6 month) and after one year
|
|
Quality of Life
Time Frame: after primary treatment (6 month) and after one year
|
KINDL questionnaire
|
after primary treatment (6 month) and after one year
|
|
Feasibility between 6 and 12 month
Time Frame: between end of primary treatment (6 month) and one year
|
Will be measured as the proportion of patients following the exercise prescription.
|
between end of primary treatment (6 month) and one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Joachim Wiskemann, PhD, National Center for Tumor Diseases
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2011
Primary Completion (Actual)
December 1, 2018
Study Completion (Actual)
March 1, 2019
Study Registration Dates
First Submitted
August 13, 2014
First Submitted That Met QC Criteria
August 13, 2014
First Posted (Estimate)
August 15, 2014
Study Record Updates
Last Update Posted (Actual)
March 13, 2019
Last Update Submitted That Met QC Criteria
March 11, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- S105-2011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Childhood Cancer
-
Dana-Farber Cancer InstituteRecruitingChildhood Cancer | Childhood Cancer SurvivorsUnited States
-
Australian & New Zealand Children's Haematology...Medical Research Future Fund; Minderoo Foundation; Children's Cancer Institute...RecruitingChildhood Cancer | Relapsed Cancer | Refractory Cancer | Childhood Leukemia | Childhood Solid Tumor | Childhood Brain TumorNew Zealand, Australia
-
Sydney Children's Hospitals NetworkGerman Cancer Research Center; Australian & New Zealand Children's Haematology... and other collaboratorsActive, not recruitingChildhood Cancer | Relapsed Cancer | Refractory Cancer | Childhood Leukemia | Childhood Solid Tumor | Childhood Brain TumorAustralia
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
University of Colorado, DenverCompletedCancer | Childhood CancerUnited States
-
Children's Cancer Group, ChinaShanghai Children's Medical Center; Shanghai Municipal Center for Disease Prevention...Recruiting
-
Emory UniversityNational Cancer Institute (NCI)Completed
-
Technical University of MunichHelmholtz Zentrum MünchenCompleted
-
University of Texas Southwestern Medical CenterWithdrawn
-
University of RochesterM.D. Anderson Cancer Center; University of Colorado, Denver; University of Pittsburgh and other collaboratorsCompleted
Clinical Trials on Multimodal Exercise Intervention
-
Hospices Civils de LyonCompletedPhysical Activity | GerontologyFrance
-
yueh chu wuRecruitingType 2 Diabetes Mellitus (T2DM)Taiwan
-
Universitetshospitalernes Center for SygeplejeNovo Nordisk A/S; University of Copenhagen; Danish Cancer Society; Lundbeck FoundationCompletedAcute LeukemiaDenmark
-
Herlev and Gentofte HospitalRigshospitalet, Denmark; University of CopenhagenCompletedNon Small Cell Lung Cancer | Advanced Cancer | Pancreas Cancer | Biliary Tract CancerDenmark
-
Hospital del SalvadorUniversity of Chile; Universidad Católica del MauleNot yet recruitingHematopoietic Stem Cell Transplantation (HSCT)Chile
-
Oregon Research InstituteRecruiting
-
University of CalgaryUniversity of British Columbia; Canadian Institutes of Health Research (CIHR); Alberta Health servicesActive, not recruitingUtilization, Health CareCanada
-
University of ÉvoraFoundation for Science and Technology, Portugal; Comprehensive Health Research...Completed
-
Nova Scotia Health AuthorityCompleted
-
Istanbul University - CerrahpasaBezmialem Vakif University; Acıbadem Atunizade HospitalNot yet recruiting